Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 1/20 | 0.48 |
| ▸ | LTA4H | P09960 | 4/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.38 |
| ▸ | CA5A | P35218 | 1/20 | 0.36 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.35 |
| ▸ | BAX | Q07812 | 1/20 | 0.35 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | HTR1B | P28222 | 2/20 | 0.34 |
| ▸ | HTR1D | P28221 | 1/20 | 0.34 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL384523 | 0.82 | CA4 (0.48) | CA4LTA4HTSHRKCNA3CA5A | |
| SCHEMBL8819925 | 0.78 | CA4 (0.43) | CA4LTA4HTSHRKCNA3CA5A | |
| SCHEMBL18638002 | 0.78 | CA4 (0.43) | CA4LTA4HTSHRKCNA3CA5A | |
| SCHEMBL6907591 | 0.76 | CA4 (0.48) | CA4LTA4HTSHRKCNA3CA5A | |
| SCHEMBL15625186 | 0.76 | CA4 (0.42) | CA4LTA4HTSHRKCNA3CA5A | |
| SCHEMBL13289 | 0.75 | LTA4H (0.50) | CA4LTA4HTSHRKCNA3CA5A | |
| Iodomethane SCHEMBL1738543 | 0.74 | CA4 (0.46) | CA4LTA4HTSHRKCNA3CA5A | |
| SCHEMBL16415989 | 0.73 | LTA4H (0.47) | CA4LTA4HTSHRKCNA3CA5A | |
| SCHEMBL8113527 | 0.73 | LTA4H (0.47) | CA4LTA4HTSHRKCNA3CA5A | |
| SCHEMBL11871889 | 0.73 | LTA4H (0.47) | CA4LTA4HTSHRKCNA3CA5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119585362-A | Polycarbonate resin composition and molded article | 三菱工程塑料株式会社 | 2025-03-07 | — | — | CN | disclosed |
| CN-118393811-B | Patterning composition, patterning film, patterning substrate, semiconductor device, and method of manufacturing the same | 珠海基石科技有限公司 | 2024-09-03 | — | — | CN | disclosed |
| CN-118393812-B | Patterning composition, patterning film, patterning substrate, semiconductor device, and method of manufacturing the same | 珠海基石科技有限公司 | 2024-08-30 | — | — | CN | disclosed |
| CN-118244581-B | Composition and preparation method thereof, patterned film, patterned substrate, semiconductor device and preparation method thereof | 珠海基石科技有限公司 | 2024-08-13 | — | — | CN | disclosed |
| CN-118393811-A | Patterning composition, patterning film, patterning substrate, semiconductor device, and method of manufacturing the same | 珠海基石科技有限公司 | 2024-07-26 | — | — | CN | disclosed |
| CN-118393812-A | Patterning composition, patterning film, patterning substrate, semiconductor device, and method of manufacturing the same | 珠海基石科技有限公司 | 2024-07-26 | — | — | CN | disclosed |
| CN-118244581-A | Composition and preparation method thereof, patterned film, patterned substrate, semiconductor device and preparation method thereof | 珠海基石科技有限公司 | 2024-06-25 | — | — | CN | disclosed |
| US-20240034930-A1 | PATTERNING MATERIAL, PATTERNING COMPOSITION, AND PATTERN FORMING METHOD | HUAWEI TECHNOLOGIES CO., LTD. (CN) | 2024-02-01 | — | — | US | disclosed |
| CN-116134174-A | Thermoplastic composition for laser direct structuring | MEP欧洲有限公司 | 2023-05-16 | — | — | CN | disclosed |
| WO-2022218315-A1 | PATTERNING MATERIAL, PATTERNING COMPOSITION, AND PATTERN FORMING METHOD | 华为技术有限公司 | 2022-10-20 | — | — | WO | disclosed |
| US-20130149296-A1 | Salts of Isophosphoramide Mustard and Analogs Thereof As Anti-Tumor Agents | DEKK-TEC, INC. | 2013-06-13 | — | — | US | disclosed |
| CN-102341175-A | Selective hydrogenation catalyst and methods of making and using same | CHEVRON PHILLIPS CHEMICAL CO | 2012-02-01 | — | — | CN | disclosed |
| EP-2403642-A2 | SELECTIVE HYDROGENATION CATALYST AND METHODS OF MAKING AND USING SAME | Chevron Phillips Chemical Company LP (US) | 2012-01-11 | — | — | EP | disclosed |
| US-20100305296-A1 | Catalyst for Producing Polyester and Method for Producing Polyester | TORAY INDUSTRIES INC. (JP) | 2010-12-02 | — | — | US | disclosed |
| WO-2010101736-A2 | SELECTIVE HYDROGENATION CATALYST AND METHODS OF MAKING AND USING SAME | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2010-09-10 | — | — | WO | disclosed |
| US-20100228065-A1 | Selective Hydrogenation Catalyst and Methods of Making and Using Same | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2010-09-09 | — | — | US | disclosed |
| US-7612148-B2 | Hydrogenation catalyst composition and method for hydrogenation of conjugated diene polymer | TSRC CORPORATION (TW) | 2009-11-03 | — | — | US | disclosed |
| US-20080146733-A1 | Hydrogenation catalyst composition and method for hydrogenation of conjugated diene polymer | TSRC CORPORATION (TW) | 2008-06-19 | — | — | US | disclosed |
| US-4391761-A | Process for the production of aryl phosphonyl compounds | BAYER AKTIENGESELLSCHAFT (DE) | 1983-07-05 | — | — | US | disclosed |
| US-4377537-A | FROM TRIARYL PHOSPHITE AND ALKYL PHOSPHITE OR PHOSPHONOUS ACID DIARYL ESTER AND PHOSPHONOUS ACID DIALKYL ESTER | BAYER AKTIENGESELLSCHAFT (DE) | 1983-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130149296-A1 | Salts of Isophosphoramide Mustard and Analogs Thereof As Anti-Tumor Agents | HASPIN, ATIC, WEE1 | CA4 814/4885LTA4H 2817/4885TSHR 3055/4885 |
| US-20100305296-A1 | Catalyst for Producing Polyester and Method for Producing Polyester | AQP4, PNMT, NEFM | CA4 473/4885LTA4H 871/4885TSHR 3845/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.